Rheumatology International

, Volume 26, Issue 1, pp 70–73 | Cite as

First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature

Case Report
First Online:
Received:
Accepted:

Abstract

The occurrence of supraventricular tachycardia after high-dose intravenous methylprednisolone pulse therapy (HIVMPT) in a patient with active rheumatoid arthritis is described for the first time. This case report further expands the range of arrhythmias that can occur with HIVMPT. Other arrhythmias previously reported to occur after HIVMPT include atrial fibrillation, atrial flutter, junctional rhythm, and ventricular tachycardia. To the best of our knowledge, supraventricular tachycardia has not been reported previously, although severe bradycardia, hypotension, asystole, cardiovascular collapse, and sudden death have been documented. A review of the literature indicates that these case reports not withstanding, HIVMPT is generally safe, and cardiovascular toxicity is rare. However, close supervision with repeated measurements of blood pressure, electrocardiogram, and blood electrolytes is mandatory during and immediately after HIVMPT, especially for patients with pre-existing cardiovascular disease, and the lowest effective dose of methylprednisolone should be infused at a slow rate.

Keywords

Adverse effects Arthritis rheumatoid Arrhythmias Human Infusions intravenous Methylprednisolone Supraventricular tachycardia 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Arlet J (1984) Pulse corticoid therapy in rheumatology. Presse Med 13:1269–1271Google Scholar
  2. 2.
    Badsha H, Edwards CJ (2003) Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum 32:370–377Google Scholar
  3. 3.
    Baethge BA, Lidsky MD, Goldberg JW (1992) A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease. Ann Pharmacother 26:316–320Google Scholar
  4. 4.
    Miller JJ III (1980) Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. Pediatrics 65:989–994Google Scholar
  5. 5.
    Radia M, Furst DE (1988) Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. J Rheumatol 15:242–246Google Scholar
  6. 6.
    Erstad BL (1989) Severe cardiovascular adverse effects in association with acute, high-dose corticosteroid administration. DICP 23:1019–1023Google Scholar
  7. 7.
    Garrett R, Paulus H (1980) Complications of intravenous methylprednisolone pulse therapy. Arthritis Rheum 23:677Google Scholar
  8. 8.
    Aslam AK, Vasavada BC, Sacchi TJ, Khan IA (2001) Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone. Am J Ther 8:303–305Google Scholar
  9. 9.
    Moretti R, Torre P, Antonello RM, Zorzon M, Cazzato G (2000) Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednisolone: a possible prophylactic treatment. Eur J Neurol 7:130Google Scholar
  10. 10.
    McLuckie AE, Savage RW (1993) Atrial fibrillation following pulse methylprednisolone therapy in an adult. Chest 104:622–623Google Scholar
  11. 11.
    Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T (1988) Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 2:29–31PubMedGoogle Scholar
  12. 12.
    Chikanza C, Fernandes L (1991) Arrhythmia after pulse methylprednisolone therapy. Br J Rheumatol 30:392–393Google Scholar
  13. 13.
    Guillen EL, Ruiz AM, Bugallo JB (1998) Hypotension, bradycardia, and asystole after high-dose intravenous methylprednisolone in a monitored patient. Am J Kidney Dis 32:E4Google Scholar
  14. 14.
    Belmonte MA, Cequiere A, Roig-Escofet D (1986) Severe ventricular arrhythmia after methylprednisolone pulse therapy in rheumatoid arthritis. J Rheumatol 13:477–479Google Scholar
  15. 15.
    Bocanegra TS, Castaneda MO, Espinoza LR, Vasey FB, Germain BF (1981) Sudden death after methylprednisolone pulse therapy. Ann Intern Med 95:122Google Scholar
  16. 16.
    Cohen IJ (1993) Cardiovascular collapse after high dose methylprednisolone. Pediatr Hematol Oncol 10:v-viiGoogle Scholar
  17. 17.
    Kucukosmanoglu O, Karabay A, Ozbarlas N, Noyan A, Anarat A (1998) Marked bradycardia due to pulsed and oral methylprednisolone therapy in a patient with rapidly progressive glomerulonephritis. Nephron 80:484Google Scholar
  18. 18.
    Moses RE, McCormick A, Nickey W (1981) Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 95:781–782Google Scholar
  19. 19.
    Pudil R, Hrncir Z (2001) Severe bradycardia after a methylprednisolone “minipulse” treatment. Arch Intern Med 161:1778–1779Google Scholar
  20. 20.
    Schult M, Lohmann D, Knitsch W, Kuse ER, Nashan B (1999) Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy. Transplantation 67:1497–1498Google Scholar
  21. 21.
    Tvede N, Nielsen LP, Andersen V (1986) Bradycardia after high-dose intravenous methylprednisolone therapy. Scand J Rheumatol 15:302–304Google Scholar
  22. 22.
    Wollheim FA (1984) Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol Suppl 54:27–32Google Scholar
  23. 23.
    Liebling MR, Leib E, McLaughlin K, Blocka K, Furst DE, Nyman K, Paulus HE (1981) Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med 94:21–26Google Scholar
  24. 24.
    Nasswetter G, Pineiro DJ, Garcia Morteo OM, Maldonado Cocco JA, Barreira JC, Vazquez BM (1984) Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy. Clin Rheumatol 3:29–31Google Scholar
  25. 25.
    Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA (2000) Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 23:449–461Google Scholar
  26. 26.
    Baethge BA, Lidsky MD (1986) Intractable hiccups associated with high-dose intravenous methylprednisolone therapy. Ann Intern Med 104:58–59Google Scholar
  27. 27.
    Fujimoto S, Kondoh H, Yamamoto Y, Hisanaga S, Tanaka K (1990) Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy. Am J Nephrol 10:231–236Google Scholar
  28. 28.
    Ozen S, Tokgozoglu L, Saatci U (1992) Are late potentials operative in arrhythmias following methylprednisolone pulse therapy. Int J Cardiol 36:234–235CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Rheumatology Division, Department of MedicineMubarak Al Kabeer HospitalKuwait
  2. 2.Department of Medicine, Faculty of MedicineKuwait UniversitySafatKuwait

Personalised recommendations